TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Taysha Gene Therapies (TSHA) Making Progress on Crucial Rett Syndrome Treatment [Yahoo! Finance]
Taysha Gene Therapies (TSHA) had its price target raised by Canaccord Genuity Group Inc. from $14.00 to $17.00. They now have a "buy" rating on the stock.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies (TSHA) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Taysha Gene Therapies (TSHA) was upgraded by Truist Financial Corporation to "strong-buy".
Form 4 Taysha Gene Therapies, For: Apr 10 Filed by: Nagendran Sukumar
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
Form 10-K Taysha Gene Therapies, For: Dec 31
Form 8-K Taysha Gene Therapies, For: Mar 19
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.